1. Home
  2. CYTH vs MOGO Comparison

CYTH vs MOGO Comparison

Compare CYTH & MOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • MOGO
  • Stock Information
  • Founded
  • CYTH 1990
  • MOGO 2003
  • Country
  • CYTH United States
  • MOGO Canada
  • Employees
  • CYTH N/A
  • MOGO N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • MOGO
  • Sector
  • CYTH Health Care
  • MOGO
  • Exchange
  • CYTH Nasdaq
  • MOGO Nasdaq
  • Market Cap
  • CYTH 35.5M
  • MOGO 35.8M
  • IPO Year
  • CYTH N/A
  • MOGO N/A
  • Fundamental
  • Price
  • CYTH $1.26
  • MOGO $1.54
  • Analyst Decision
  • CYTH Strong Buy
  • MOGO Strong Buy
  • Analyst Count
  • CYTH 3
  • MOGO 1
  • Target Price
  • CYTH $3.20
  • MOGO $8.00
  • AVG Volume (30 Days)
  • CYTH 25.8K
  • MOGO 67.2K
  • Earning Date
  • CYTH 08-12-2024
  • MOGO 08-08-2024
  • Dividend Yield
  • CYTH N/A
  • MOGO N/A
  • EPS Growth
  • CYTH N/A
  • MOGO N/A
  • EPS
  • CYTH N/A
  • MOGO N/A
  • Revenue
  • CYTH $1,126,444.00
  • MOGO $49,463,235.00
  • Revenue This Year
  • CYTH $28.30
  • MOGO $13.79
  • Revenue Next Year
  • CYTH $14.19
  • MOGO $12.72
  • P/E Ratio
  • CYTH N/A
  • MOGO N/A
  • Revenue Growth
  • CYTH N/A
  • MOGO N/A
  • 52 Week Low
  • CYTH $0.89
  • MOGO $0.95
  • 52 Week High
  • CYTH $2.12
  • MOGO $2.85
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 48.10
  • MOGO 49.64
  • Support Level
  • CYTH $1.13
  • MOGO $1.49
  • Resistance Level
  • CYTH $1.40
  • MOGO $1.57
  • Average True Range (ATR)
  • CYTH 0.09
  • MOGO 0.06
  • MACD
  • CYTH 0.02
  • MOGO 0.02
  • Stochastic Oscillator
  • CYTH 48.15
  • MOGO 47.62

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

Share on Social Networks: